1. Home
  2. GPMT vs ZURA Comparison

GPMT vs ZURA Comparison

Compare GPMT & ZURA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GPMT
  • ZURA
  • Stock Information
  • Founded
  • GPMT 2015
  • ZURA 2022
  • Country
  • GPMT United States
  • ZURA United States
  • Employees
  • GPMT N/A
  • ZURA N/A
  • Industry
  • GPMT Real Estate Investment Trusts
  • ZURA Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • GPMT Real Estate
  • ZURA Health Care
  • Exchange
  • GPMT Nasdaq
  • ZURA Nasdaq
  • Market Cap
  • GPMT 122.3M
  • ZURA 137.2M
  • IPO Year
  • GPMT 2017
  • ZURA N/A
  • Fundamental
  • Price
  • GPMT $2.83
  • ZURA $3.74
  • Analyst Decision
  • GPMT Buy
  • ZURA Buy
  • Analyst Count
  • GPMT 3
  • ZURA 9
  • Target Price
  • GPMT $3.13
  • ZURA $11.00
  • AVG Volume (30 Days)
  • GPMT 250.4K
  • ZURA 3.1M
  • Earning Date
  • GPMT 11-05-2025
  • ZURA 11-07-2025
  • Dividend Yield
  • GPMT 7.07%
  • ZURA N/A
  • EPS Growth
  • GPMT N/A
  • ZURA N/A
  • EPS
  • GPMT N/A
  • ZURA N/A
  • Revenue
  • GPMT N/A
  • ZURA N/A
  • Revenue This Year
  • GPMT N/A
  • ZURA N/A
  • Revenue Next Year
  • GPMT $29.04
  • ZURA N/A
  • P/E Ratio
  • GPMT N/A
  • ZURA N/A
  • Revenue Growth
  • GPMT N/A
  • ZURA N/A
  • 52 Week Low
  • GPMT $1.61
  • ZURA $0.97
  • 52 Week High
  • GPMT $3.66
  • ZURA $4.90
  • Technical
  • Relative Strength Index (RSI)
  • GPMT 52.96
  • ZURA 62.89
  • Support Level
  • GPMT $2.57
  • ZURA $3.15
  • Resistance Level
  • GPMT $3.03
  • ZURA $4.12
  • Average True Range (ATR)
  • GPMT 0.08
  • ZURA 0.32
  • MACD
  • GPMT 0.01
  • ZURA -0.03
  • Stochastic Oscillator
  • GPMT 92.80
  • ZURA 48.95

About GPMT Granite Point Mortgage Trust Inc.

Granite Point Mortgage Trust Inc focuses on directly originating, investing in, and managing senior floating rate commercial mortgage loans and other debt and debt-like commercial real estate investments. The company constructs its investment portfolio on a loan-by-loan basis, emphasizing rigorous credit underwriting, selectivity, and diversification, and assesses each investment from a fundamental value perspective relative to other opportunities available in the market. It typically provides intermediate-term bridge or transitional financing for a variety of purposes, including acquisitions, recapitalizations, refinancing, and a range of business plans, including lease-up, renovation, repositioning and repurposing of the property.

About ZURA Zura Bio Limited

Zura Bio Ltd is a clinical-stage, multi-asset immunology company developing novel dual-pathway antibodies for autoimmune and inflammatory diseases. It is developing three assets which have completed Phase I/Ib studies and are Phase II ready. It is developing a portfolio of therapeutic indications for tibulizumab and torudokimab with a goal of demonstrating their efficacy, safety, and dosing convenience in autoimmune and inflammatory diseases.

Share on Social Networks: